BN Business News
Add your company to Business Communicator →

BUSINESS NEWS

Search Business News

Find articles by title or summary.

10/13/2023

Forest Service Corrects Recreation Fee Sites Proposal

The US Forest Service has corrected a document published in the Federal Register on September 21, 2023, regarding new recreation fee sites on the Shoshone National Forest, which initially contained incorrect contact information and supplementary details.

10/13/2023

NHTSA Seeks Comments on EMS Education Agenda 2050

The NHTSA Office of Emergency Medical Services is requesting comments from various stakeholders on its plan to re-envision the 2000 EMS Education Agenda for the Future: A Systems Approach, with the goal of creating EMS Education Agenda 2050.

10/13/2023

U.S. ITC Initiates Antidumping and Countervailing Duty Investigations into Aluminum Extrusions from 13 Countries

The U.S. International Trade Commission (ITC) has initiated antidumping and countervailing duty investigations into aluminum extrusions imported from China, Colombia, Dominican Republic, Ecuador, India, Indonesia, Italy, Malaysia, Mexico, South Korea, Taiwan, Thailand, Turkey, United Arab Emirates, and Vietnam, which are alleged to be sold at less than fair value and subsidized by their governments.

10/13/2023

FDA Announces Final Guidance on Prior Notice of Imported Food Questions and Answers

The Food and Drug Administration (FDA) has released a final guidance document titled "Prior Notice of Imported Food Questions and Answers (Edition 4): Guidance for Industry," which updates the current version by including three new questions and makes other technical changes, finalizing a draft guidance from September 13, 2022.

10/13/2023

FACOSH Rechartering Notice from OSHA

The Occupational Safety and Health Administration (OSHA) is rechartering the Federal Advisory Council on Occupational Safety and Health (FACOSH) for a two-year term, as mandated by the Federal Advisory Committee Act (FACA) and in compliance with the Committee Management Secretariat, General Services Administration.

10/13/2023

SBA Investment Capital Advisory Committee Meeting

The U.S. Small Business Administration (SBA) will host its first meeting of the SBA Investment Capital Advisory Committee on October 25, 2023, where members will provide independent advice and recommendations on investment market trends, innovation, and policy affecting small businesses' access to capital.

10/13/2023

Federal Agencies Extend Regulatory Capital Reporting Collection Without Revision, Request OMB Review

The Office of the Comptroller of the Currency (OCC), the Federal Reserve Board (Board), and the Federal Deposit Insurance Corporation (FDIC) are extending the Regulatory Capital Reporting for Institutions Subject to the Advanced Capital Adequacy Framework (FFIEC 101) collection without revision for three years, following a 60-day public comment period that ended on August 28, 2023, and no comments were received.

10/12/2023

Delegations of Authority Revised at USDA

The USDA has updated its delegations of authority to reflect recent changes and additions, primarily affecting the Secretary of Agriculture and general officers of the U.S. Department of Agriculture.

10/12/2023

Federal Government Seeks Comments on Insurance Survey

The U.S. government is requesting public comments on a proposed survey of insurance transactions with foreign persons, which will be submitted to the Office of Management and Budget (OMB) for review and approval.

10/12/2023

FDA Submits Proposed Information Collection for OMB Review

The Food and Drug Administration has voluntarily submitted a proposed collection of information to the Office of Management and Budget for review and clearance under the Paperwork Reduction Act of 1995, following allegations of regulatory misconduct.

10/12/2023

FDA Clears CYTOXAN Drug Products for Sale

The FDA has determined that CYTOXAN (cyclophosphamide) drug products were not withdrawn from sale due to safety or effectiveness concerns. The FDA will continue to approve abbreviated new drug applications (ANDAs) for these products as long as they meet regulatory requirements.